The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Features and Prognosis of Intraductal Papillary Mucinous Neoplasm of the Pancreas

췌관내 유두상점액종양의 임상적 특징 및 예후

  • Kim, Tae Hyeon (Department of Internal Medicine, Wonkwang University College of Medicine)
  • 김태현 (원광대학교 의과대학 내과학교실)
  • Published : 2014.02.01
⟨ Previous Next ⟩

Abstract

Intraductal papillary mucinous neoplasm is frequently found recently and have recognized as precancerous lesions to pancreatic cancer that characterized by papillary growth of the ductal epithelium with rich mucin production and cystic dilatation of the main pancreatic duct and/or its branches. These tumors are asymptomatic and often multifocal. Preoperative differentiation between benign and malignant lesions is important to select the most appropriate treatment and to improve prognosis. Surgical resection is the treatment of choice to avoid malignant transformation when predictive factors for malignancy are present. These factors include mural nodule in the cyst, main pancreatic duct dilation, thick septum, cyst greater than 3 cm, atypias in the cyst fluid and the presence of symptoms. The follow-up of these patients who do not undergo surgical resection, is of great importance, since patients with IPMN appear to be at risk for pancreatic cancer. Patients who retain a portion of their pancreas following resection of an IPMN need to be followed up with periodic imaging to detect recurrences and metachronous lesions.

Keywords

References

  1. Jang JY, Hwang DW, Kim MA, et al. Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms. Ann Surg Oncol 2011;18:644-650. https://doi.org/10.1245/s10434-010-1331-6
  2. Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg 2007;11:338-344. https://doi.org/10.1007/s11605-006-0069-8
  3. Hwang DW, Jang JY, Lee SE, Lim CS, Lee KU, Kim SW. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg 2012;397:93-102. https://doi.org/10.1007/s00423-010-0674-6
  4. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007;246:644-651. https://doi.org/10.1097/SLA.0b013e318155a9e5
  5. Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 2008;15:199-205. https://doi.org/10.1245/s10434-007-9603-5
  6. Akita H, Takeda Y, Hoshino H, et al. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am J Surg 2011;202:214-219. https://doi.org/10.1016/j.amjsurg.2010.06.020
  7. Bastid C, Bernard JP, Sarles H, Payan MJ, Sahel J. Mucinous ductal ectasia of the pancreas: a premalignant disease and a cause of obstructive pancreatitis. Pancreas 1991;6:15-22. https://doi.org/10.1097/00006676-199101000-00003
  8. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2010;139:708-713. https://doi.org/10.1053/j.gastro.2010.07.025
  9. Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010;105:2079-2084. https://doi.org/10.1038/ajg.2010.122
  10. De Jong K, Nio CY, Hermans JJ, et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010;8:806-811. https://doi.org/10.1016/j.cgh.2010.05.017
  11. Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-807. https://doi.org/10.2214/AJR.07.3340
  12. Kosmahl M, Pauser U, Peters K, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004;445:168-178.
  13. Allen PJ, D'Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006;244:572-582.
  14. Yoon WJ, Yoon YB, Lee KH, et al. The cystic neoplasms of the pancreas in Korea. Korean J Med 2006;70:261-267.
  15. Ingkakul T, Warshaw AL, Fernandez-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions. Pancreas 2011;40:779-780. https://doi.org/10.1097/MPA.0b013e31821f27fb
  16. Capurso G, Boccia S, Salvia R, et al. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol 2013;108:1003-1009. https://doi.org/10.1038/ajg.2013.42
  17. Jang JW, Kim MH, Jeong SU, et al. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J Gastroenterol Hepatol 2013;28:731-738. https://doi.org/10.1111/jgh.12121
  18. Crippa S, Fernandez-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010;8:213-219. https://doi.org/10.1016/j.cgh.2009.10.001
  19. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788-797. https://doi.org/10.1097/01.sla.0000128306.90650.aa
  20. Abdeljawad K, Vemulapalli KC, Schmidt CM, et al. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc 2013 Oct 2 [Epub]. http://dx.doi.org/10.1016/j.gie.2013.08.024.
  21. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-197. https://doi.org/10.1016/j.pan.2012.04.004
  22. Kobayashi G, Fujita N, Noda Y, et al. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. J Gastroenterol 2005;40:744-751. https://doi.org/10.1007/s00535-005-1619-7
  23. Carbognin G, Zamboni G, Pinali L, et al. Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging 2006;31:320-325. https://doi.org/10.1007/s00261-004-0127-1
  24. Farrell JJ, Fernandez-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology 2013;144:1303-1315. https://doi.org/10.1053/j.gastro.2013.01.073
  25. Wu BU, Sampath K, Berberian CE, et al. Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study. Am J Gastroenterol 2014;109:121-129. https://doi.org/10.1038/ajg.2013.334
  26. Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011;40:571-580. https://doi.org/10.1097/MPA.0b013e318215010c
  27. Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2:484-490. https://doi.org/10.1159/000064716
  28. Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008;57:1561-1565. https://doi.org/10.1136/gut.2007.145631
  29. Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas 2010;39:36-40. https://doi.org/10.1097/MPA.0b013e3181b91cd0
  30. Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 2010;251:70-75. https://doi.org/10.1097/SLA.0b013e3181c5ddc3
  31. Yoon WJ, Ryu JK, Lee JK, et al. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms. Ann Surg Oncol 2008;15:3193-3198. https://doi.org/10.1245/s10434-008-0143-4
  32. Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg 2009;249:628-634. https://doi.org/10.1097/SLA.0b013e3181a189a8
  33. Hirono S, Tani M, Kawai M, et al. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012;255:517-522. https://doi.org/10.1097/SLA.0b013e3182444231
  34. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007;133:72-79. https://doi.org/10.1053/j.gastro.2007.05.010
  35. Pais SA, Attasaranya S, Leblanc JK, Sherman S, Schmidt CM, DeWitt J. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol 2007;5:489-495. https://doi.org/10.1016/j.cgh.2006.12.007
  36. Correa-Gallego C, Warshaw AL, Fernandez-del Castillo C. Fluid CEA in IPMNs: a useful test or the flip of a coin? Am J Gastroenterol 2009;104:796-797. https://doi.org/10.1038/ajg.2008.158
  37. Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 2006;30:1561-1569. https://doi.org/10.1097/01.pas.0000213305.98187.d4
  38. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol 2002;197:201-210. https://doi.org/10.1002/path.1109
  39. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848. https://doi.org/10.1097/00000478-200407000-00001
  40. Kim J, Jang KT, Mo Park S, et al. Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas. Tumour Biol 2011;32:535-542. https://doi.org/10.1007/s13277-010-0148-z
  41. Kim KW, Park SH, Pyo J, et al. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 2014;259:72-81. https://doi.org/10.1097/SLA.0b013e31829385f7
  42. Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology 2010;138:531-540. https://doi.org/10.1053/j.gastro.2009.10.001
  43. Tajima Y, Kuroki T, Tsuneoka N, et al. Multifocal branch-duct pancreatic intraductal papillary mucinous neoplasms. Am J Surg 2008;196:e50-52. https://doi.org/10.1016/j.amjsurg.2007.10.013
  44. Salvia R, Partelli S, Crippa S, et al. Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am J Surg 2009;198:709-714. https://doi.org/10.1016/j.amjsurg.2008.10.022
  45. Crippa S, Partelli S, Falconi M. Extent of surgical resections for intraductal papillary mucinous neoplasms. World J Gastrointest Surg 2010;2:347-351. https://doi.org/10.4240/wjgs.v2.i10.347
  46. Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 2010;251:470-476. https://doi.org/10.1097/SLA.0b013e3181cf8a19
  47. Passot G, Lebeau R, Hervieu V, Ponchon T, Pilleul F, Adham M. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors. Pancreas 2012;41:137-141. https://doi.org/10.1097/MPA.0b013e318222bc9c
  48. Miller JR, Meyer JE, Waters JA, et al. Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford) 2011;13:759-766. https://doi.org/10.1111/j.1477-2574.2011.00354.x
  49. White R, D'Angelica M, Katabi N, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 2007;204:987-993. https://doi.org/10.1016/j.jamcollsurg.2006.12.040
  50. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500-1507. https://doi.org/10.1053/gast.2002.36552
  51. Kim SC, Park KT, Lee YJ, et al. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg 2008;15:183-188. https://doi.org/10.1007/s00534-007-1231-8
  52. Kang MJ, Jang JY, Lee KB, Chang YR, Kwon W, Kim SW. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative Surveillance. Ann Surg 2013 Dec 27 [Epub]. http://dx.doi.org/10.1097/SLA.0000000000000470.
  53. Gaujoux S, Brennan MF, Gonen M, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg 2011;212:590-600. https://doi.org/10.1016/j.jamcollsurg.2011.01.016
  54. Al-Haddad M, Schmidt MC, Sandrasegaran K, Dewitt J. Diagnosis and treatment of cystic pancreatic tumors. Clin Gastroenterol Hepatol 2011;9:635-648. https://doi.org/10.1016/j.cgh.2011.03.005
  55. Kang MJ, Jang JY, Kim SJ, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol 2011;9:87-93. https://doi.org/10.1016/j.cgh.2010.09.008
  56. Sahani DV, Lin DJ, Venkatesan AM, et al. Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol 2009;7:259-269. https://doi.org/10.1016/j.cgh.2008.11.008
  57. Grutzmann R, Niedergethmann M, Pilarsky C, Kloppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist 2010;15:1294-1309. https://doi.org/10.1634/theoncologist.2010-0151

Cited by

  1. Endoscopic Diagnosis of Pancreatic Cystic Tumors vol.87, pp.3, 2014, https://doi.org/10.3904/kjm.2014.87.3.251